Q2 EPS Forecast for Neumora Therapeutics Raised by Analyst
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Research analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for shares of Neumora Therapeutics in a research report issued to clients and investors on Tuesday, March 4th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings of ($0.42) […]
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) – Research analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for shares of Neumora Therapeutics in a research report issued to clients and investors on Tuesday, March 4th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings of ($0.42) […]
